Mechanism of the hypothermic effect of MPP+ administered centrally in mice

Neuropharmacology

Volumn 36, Issue 7, 1997, Pages 993-997

  Drouet, I ^a   Suaudeau, C ^a   Dourmap, N ^a   Costentin, J ^a  

^a Laboratoire DIFEMA   (France)

Author keywords

2 adrenergic receptors; Hypothermia; Mouse; MPP+; Noradrenergic neurons

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; ALPHA 2 ADRENERGIC RECEPTOR; DESIPRAMINE; DOPAMINE; HALOPERIDOL; IDAZOXAN; NEUROTOXIN; NORADRENALIN; OXIDOPAMINE; PROPRANOLOL; SCOPOLAMINE; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINERGIC TRANSMISSION; HYPOTHERMIA; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; NORADRENALIN BRAIN LEVEL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; BODY TEMPERATURE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOTHERMIA; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; OXIDOPAMINE;

EID: 0030855782     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00077-4     Document Type: Article

References (16)

1. Colboc O. and Costentin J. (1980) Evidence for thermoregulation dopaminergic receptors located in the preopticus medialis nucleus of the rat hypothalamus. Journal of Pharmacy and Pharmacology 32: 624-629.
2. Cleeter M., Cooper M. and Schapira A. H. (1992) Irreversible inhibition of mitochondrial complex I by methyl-4-phenylpyridinium: Evidence for free radical involvement. Journal of Neurochemistry 58: 786-789.
3. Glowinski J. and Iversen L. L. (1966) Regional studies of catecholamines in rat brain: the disposition of 3H-norepinephrine 3H-dopamine and 3H-DOPA in various regions of the brain. Journal of Neurochemistry 13: 655-669.
4. Haley J. J. and McCormick W. G. (1957) Pharmalogical effects produced by intracerebral injection of drugs in the conscious mouse. British Journal of Pharmacology 12: 12-15.
5. Heikkika R. E., Manzino L., Cabbat F. S. and Duvoisin R. C. (1984) Protection against the dopaminergic neurotoxicity of MPTP by monoamine oxydase inhibitors. Nature 311: 467-469.
6. Javitch J. A., Damatu R. J., Strittmatter S. M. and Snyder S. M. (1985) Parkinsonism inducing neurotoxin, MPTP: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proceedings of the National Academy of Science U.S.A. 82: 2173-2177.
7. Kamal L. A., Arbilla S. and Langer S. Z. (1981) Presynaptic modulation of the release of dopamine from rabbit caudate nucleus: differences between electrical stimulation, amphetamine and tyramine. Journal of Pharmacology and Experimental Therapeutics 216: 592-598.
8. Langsten J. W., Ballard P., Tetrud J. W. and Irwin I. (1983) Chronic parkinsonism in humans due to product of meperidine-analog synthesis. Science 219: 979-980.
9. Langsten J. W., Irwin I., Langsten E. B. and Forno L. S. (1984) 1 methyl 4 phenylpyridinium (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra. Neuroscience Letters 48: 87-92.
10. Leroux-Nicollet I., Panissaud C. and Costentin J. (1988) Involvement of norepinephrine neurons in the hypothermia induced by intracerebroventricular administration of 6-hydroxydopamine in mice, evidenced by antidepressants. Journal of Neural Transmission 74: 17-27.
11. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193: 265-275.
12. Lyden A., Bondesson U., Larsson B. S. and Lindquist N. G. (1983) Melanin affinity of MPTP, an inducer of chronic parkinsonism in humans. Acta Pharmacology and Toxicology 53: 429-432.
13. Mizuno Y., Ohta S., Tanaka M., Takamiya S., Suzuki K., Sato T., Oya H., Ozawa T. and Kagawa Y. (1989) Deficiences in complex I subunits of the respiratory chain in Parkinson's disease. Biochemistry and Biophysics Research Communications 163: 1450-1455.
14. Quan N., Xin L., Ungar A. L. and Biatteis C. M. (1992) Preoptic norepinephrine-induced hypothermia is mediated by alpha 2 adrenoreceptors. American Journal of Physiology 262:407-411.
15. Sanchez C. and Lembol H. L. (1994) The involvement of muscarinic receptor subtypes in the mediation of hypothermia, tremor and salivation in male mice. Pharmacology and Toxicology 74 (1): 35-39.
16. Suaudeau C., Bousselmame R. and Costentin J. (1992) A different balance in the sensitivity of D1 and D2 dopamine receptors accounts for differences in apomorphine-induced hypothermic effects in Swiss and C3H mice. Neuropharmacology 31: 1115-1119.